![David Hwang](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Hwang worked as a Senior Director of Strategy & Corporate Development at Agilent Technologies, Inc. from 2007 to 2016.
He also worked as a Director at Molecular Assemblies, Inc. from 2019 to 2022.
Mr. Hwang received his undergraduate degree from Brandeis University and his MBA from Rutgers State University of New Jersey.
| Sociétés | Poste | Fin |
|---|---|---|
Molecular Assemblies, Inc.
 Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Directeur/Membre du Conseil | 08/06/2022 |
| AGILENT TECHNOLOGIES, INC. | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
Agilent Technologies, Inc.
 Agilent Technologies, Inc. Medical SpecialtiesHealth Technology Engages in life sciences, diagnostics and applied chemical markets | Health Technology |
Brandeis University
 Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Assemblies, Inc.
Molecular Assemblies, Inc. BiotechnologyHealth Technology Develops enzymatic DNA synthesis technology used for making DNA-based products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
